![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MEP1A |
Gene summary for MEP1A |
![]() |
Gene information | Species | Human | Gene symbol | MEP1A | Gene ID | 4224 |
Gene name | meprin A subunit alpha | |
Gene Alias | PPHA | |
Cytomap | 6p12.3 | |
Gene Type | protein-coding | GO ID | GO:0006508 | UniProtAcc | Q16819 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4224 | MEP1A | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.33e-12 | 8.21e-01 | -0.1808 |
4224 | MEP1A | HTA11_78_2000001011 | Human | Colorectum | AD | 4.57e-10 | 6.56e-01 | -0.1088 |
4224 | MEP1A | HTA11_347_2000001011 | Human | Colorectum | AD | 2.29e-26 | 9.11e-01 | -0.1954 |
4224 | MEP1A | HTA11_411_2000001011 | Human | Colorectum | SER | 1.24e-08 | 1.17e+00 | -0.2602 |
4224 | MEP1A | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.25e-07 | 1.13e+00 | -0.2196 |
4224 | MEP1A | HTA11_83_2000001011 | Human | Colorectum | SER | 6.12e-05 | 4.11e-01 | -0.1526 |
4224 | MEP1A | HTA11_696_2000001011 | Human | Colorectum | AD | 2.00e-05 | 3.75e-01 | -0.1464 |
4224 | MEP1A | HTA11_5212_2000001011 | Human | Colorectum | AD | 9.42e-11 | 1.13e+00 | -0.2061 |
4224 | MEP1A | HTA11_99999971662_82457 | Human | Colorectum | MSS | 6.42e-13 | 5.72e-01 | 0.3859 |
4224 | MEP1A | A002-C-010 | Human | Colorectum | FAP | 3.14e-02 | -1.38e-01 | 0.242 |
4224 | MEP1A | A002-C-116 | Human | Colorectum | FAP | 3.85e-03 | -1.53e-01 | -0.0452 |
4224 | MEP1A | HCC1_Meng | Human | Liver | HCC | 3.72e-19 | 9.86e-02 | 0.0246 |
4224 | MEP1A | S014 | Human | Liver | HCC | 1.00e-14 | 7.56e-01 | 0.2254 |
4224 | MEP1A | S015 | Human | Liver | HCC | 2.75e-17 | 1.30e+00 | 0.2375 |
4224 | MEP1A | S016 | Human | Liver | HCC | 9.35e-20 | 1.30e+00 | 0.2243 |
4224 | MEP1A | Pat01-B | Human | Stomach | GC | 2.25e-43 | 7.71e-01 | 0.5754 |
4224 | MEP1A | Pat02-B | Human | Stomach | GC | 8.40e-04 | 1.14e-01 | 0.0368 |
4224 | MEP1A | Pat03-B | Human | Stomach | GC | 9.48e-26 | 5.41e-01 | 0.3693 |
4224 | MEP1A | Pat17-B | Human | Stomach | GC | 9.13e-06 | 2.49e-01 | 0.3109 |
4224 | MEP1A | Pat19-B | Human | Stomach | GC | 3.48e-04 | 1.69e-01 | 0.0826 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MEP1A | SNV | Missense_Mutation | novel | c.598A>G | p.Thr200Ala | p.T200A | Q16819 | protein_coding | tolerated(0.07) | probably_damaging(0.91) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MEP1A | SNV | Missense_Mutation | c.550N>A | p.Leu184Ile | p.L184I | Q16819 | protein_coding | tolerated(0.92) | benign(0.007) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
MEP1A | SNV | Missense_Mutation | rs778875477 | c.764N>A | p.Arg255Gln | p.R255Q | Q16819 | protein_coding | tolerated(0.1) | probably_damaging(1) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
MEP1A | SNV | Missense_Mutation | c.1373N>A | p.Arg458Gln | p.R458Q | Q16819 | protein_coding | tolerated(0.05) | probably_damaging(0.96) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MEP1A | SNV | Missense_Mutation | rs565677690 | c.2122N>T | p.Arg708Cys | p.R708C | Q16819 | protein_coding | deleterious(0) | possibly_damaging(0.803) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MEP1A | SNV | Missense_Mutation | novel | c.1684N>G | p.Ser562Gly | p.S562G | Q16819 | protein_coding | tolerated(1) | benign(0.007) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
MEP1A | SNV | Missense_Mutation | c.348N>T | p.Glu116Asp | p.E116D | Q16819 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MEP1A | SNV | Missense_Mutation | novel | c.1284N>T | p.Glu428Asp | p.E428D | Q16819 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MEP1A | SNV | Missense_Mutation | novel | c.884N>A | p.Ala295Asp | p.A295D | Q16819 | protein_coding | tolerated(0.3) | benign(0.006) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MEP1A | SNV | Missense_Mutation | novel | c.1741N>C | p.Phe581Leu | p.F581L | Q16819 | protein_coding | deleterious(0) | probably_damaging(0.958) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |